Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 2-pack Carton (Lira Carton 2pack Ns V1)
Liraglutide Injection
Product Images NDC 72603-745
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Liraglutide (NDC 72603-745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL 3-pack Carton (Lira Carton 3pack Ns V1)
This is a description for a medication called Liraglutide Injection, containing 6 mg per mL. The prefilled pen provides doses of 0.6 mg, 1.2 mg, or 1.8 mg. It is recommended to refrigerate and not freeze the medication. Each pen should be discarded after 30 days from first use. The product literature advises against transferring the medication to a syringe. The container closure is sterile and nonpyrogenic, and not made with natural rubber latex. Pen needles are not included. For single-patient use only.*
Structural Formula (Lira Fig 1)
Figure 2 (Lira Fig 2)
Figure 3 (Lira Fig 3)
Figure 4 (Lira Fig 4)
Flow Check Symbol (Lira Flow Check)
Figure A (Lira Ifu A)
Figure B (Lira Ifu B)
Figure C (Lira Ifu C)
Figure D (Lira Ifu D)
Figure E (Lira Ifu E)
Figure F (Lira Ifu F)
Figure G (Lira Ifu G)
Figure H (Lira Ifu H)
Figure I (Lira Ifu I)
Figure J (Lira Ifu J)
Figure K (Lira Ifu K)
Figure L (Lira Ifu L)
These are different dosages of a medication that have been selected, with amounts of 0.6 mg, 1.2 mg, and 1.8 mg chosen. The various dosages indicate potential options for usage or administration.*
Figure M (Lira Ifu M V2)
This text mentions different body parts that may be evaluated or described, such as upper arms, stomach, and thighs. It could be related to a fitness program, body measurements, clothing fit, or a medical examination.*
Figure N (Lira Ifu N V2)
Liraglutide Needle (Lira Ifu Needle)
Figure O (Lira Ifu O V2)
Figure P (Lira Ifu P V2)
Liraglutide Injection Pen (Lira Ifu Pen)
This is a description of a Liraglutide Injection Pen, which consists of components such as a rubber stopper, pen cap, cartridge tip, cartridge, pointer, dose selector, and dose display. The pen is used for injecting Liraglutide.*
Figure Q (Lira Ifu Q V2)
Figure R (Lira Ifu R)
Principal Display Panel – Liraglutide Injection 18 mg Per 3 mL Syringe Label (Lira Syringe Ns V1)
This text provides information about Liraglutide Injection, containing 18 mg per 3 mL (6 mg per mL). It is important to note that this medication is for single-patient use only and should be administered subcutaneously. The pre-filled pen delivers different doses and should be discarded 30 days after first use. Additionally, it should be refrigerated before the first use and not frozen. The product is manufactured in China for Northstar Healthcare and Orhar RLLC in Memphis, TN.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
